跳至主要内容
临床试验/NCT06556186
NCT06556186尚未招募不适用

Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University0 个研究点目标入组 600 人开始时间: 2024年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
600
主要终点
pituitary hormone levels

研究概览

简要总结

The investigators carried out a multi-center comparative study, involving hospitals including the Second Affiliated Hospital of Zhejiang University School of Medicine, Peking Union Medical College Hospital, West China Hospital, Wenzhou First Hospital, and Li Huili Hospital. This study aimed to compare the efficacy of medication and surgery for specific subtypes of microadenomas and clearly defined macroadenomas (Knosp grades 0-2), in order to determine which is more effective and which has fewer benefits, thereby enhancing the evidence base.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Prolactin level greater than three times the normal upper limit
  • MRI indicates Knosp Grade 0-2 pituitary adenoma

排除标准

  • MRI indicates Knosp grade 3-4 pituitary adenoma
  • Taking antidepressants or other psychotropic drugs
  • Patients allergic to bromocriptine or cannot tolerate surgery
  • Women defined as surgical infertility (i.e. hysterectomy, bilateral salpingectomy, or bilateral oophorectomy), or amenorrhea for more than 2 years
  • Critical illness patients, such as those with progressive consciousness disorders, cerebral hernias, and other emergency situations

研究组 & 干预措施

Operation group

Experimental

Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy

干预措施: Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy (Procedure)

Drug group

Active Comparator

Bromocriptin 2.5mg, 2-3 times a day

干预措施: Bromocriptin 2.5mg, 2-3 times a day (Drug)

结局指标

主要结局

pituitary hormone levels

时间窗: At 1, 3, 6, 9 and 12 months postoperatively

Recheck pituitary hormones (PRL, GH, ACTH, etc.)

pituitary MRI

时间窗: At 1,6 and 12 months postoperatively

Recheck pituitary MRI

次要结局

  • sexual function evaluation(At 1,6 and 12 months postoperatively)
  • menstrual condition(At 6 and 12 months postoperatively)
  • lactation(At 1,6 and 12 months postoperatively)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

相似试验